Diazepinone HBV capsid assembly modulators.
Capsid
Diazepinone
HBV
Journal
Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377
Informations de publication
Date de publication:
15 09 2022
15 09 2022
Historique:
received:
30
03
2022
revised:
19
05
2022
accepted:
23
05
2022
pubmed:
2
6
2022
medline:
27
7
2022
entrez:
1
6
2022
Statut:
ppublish
Résumé
The HBV capsid core protein serves a number of important functions in the viral life cycle enabling chronic HBV infection to persist, and therefore is a promising drug target. Interfering with capsid assembly has shown efficacy in clinical trials with small molecule capsid assembly modulators (CAMs). Herein is described the further optimization of a progressive series of diazepinone HBV CAMs.
Identifiants
pubmed: 35644301
pii: S0960-894X(22)00299-2
doi: 10.1016/j.bmcl.2022.128823
pii:
doi:
Substances chimiques
Antiviral Agents
0
Capsid Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
128823Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.